Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
About the National Institute for Innovation in Manufacturing Biopharmaceuticals
Website: NIIMBL.ORG
Established: 2017
Headquarters: Newark, DE
Consortium Organizer: University of Delaware
NIIMBL advances innovative platforms and technologies to enable faster, more flexible biopharmaceutical manufacturing production. Its collaborative ecosystem—comprising industry, academia, community colleges, and government partners—strengthens national economic security and increases agility in responding to public health emergencies, speeding patient access to life-saving medicines.
NIIMBL News
NIIMBL Awards Funding to Michigan Technological University to Advance AAV Aggregate Testing for Gene Therapy
January 27, 2026
NIIMBL’s Viral Vector Program has awarded funding to Michigan Technological University to evaluate methods for detecting adeno-associated virus (AAV) aggregation in gene therapy manufacturing...
Six Organizations Selected to Host NIIMBL eXperience for Educators
January 21, 2026
NIIMBL is pleased to announce that six organizations have been selected to host the inaugural NIIMBL eXperience for Educators this summer. Each will offer a one- or two-day program introducing K-12 educators to the biopharmaceutical industry...
New NIST Reference Material to Strengthen Quality Control for Biological Drugs
July 31, 2025
A rapidly growing category of drugs called protein-based biotherapeutics can be used to treat cancers and genetic and autoimmune disorders...
OAGi and NIIMBL Announce Release of Biopharmaceutical Manufacturing Ontologies to Advance Interoperability and Analytics
November 12, 2025
NIIMBL and the Open Applications Group, Inc. (OAGi) are proud to announce the release of a groundbreaking set of ontologies designed to enhance data interoperability and analytics capabilities across the biopharmaceutical industry…
Team led by NIIMBL is Selected for Gates Grand Challenge $10.5 Million Funding Award
October 23, 2025
Today, NIIMBL announced that a NIIMBL-led team will receive $10.5 Million in funding through the Gates Grand Challenges Program to advance exceptionally low-cost monoclonal antibody (mAb) manufacturing…
Events
2026 NIIMBL National Meeting
Building a Shared AAV Manufacturing Resource: A Public Workshop
The 10th NIIMBL National Meeting will take place in Washington, D.C., from June 23 to 25, 2026
Contacts
| Kelley Rogers | NIIMBL Federal Technical Program Officer | kelley.rogers [at] nist.gov (kelley[dot]rogers[at]nist[dot]gov) |
| Jorge Lamboy | NIIMBL Federal Technical Program Manager | jorge.lamboy [at] nist.gov (jorge[dot]lamboy[at]nist[dot]gov) |
| Christina Jones | NIIMBL Federal Education and Workforce Development Program Manager | christina.jones [at] nist.gov (christina[dot]jones[at]nist[dot]gov) |
| Adrienne Cheng | NIIMBL Federal Technical Program Manager | adrienne.cheng [at] nist.gov (adrienne[dot]cheng[at]nist[dot]gov) |
| Shelly Pollard | NIIMBL Federal Communications | shelly.pollard [at] nist.gov (shelly[dot]pollard[at]nist[dot]gov) |